Klinische Forschung Berlin adds more studies to Clariness’ innovative patient recruitment platform, ClinLife Registry
July 11 2022
The global patient recruitment specialist Clariness today announces the extension of patient recruitment services for research institute, Klinische Forschung Berlin.
Berlin, Germany – Clariness, a leading global patient recruitment organization, has extended its contract with Klinische Forschung Berlin GbR (Klifo Berlin GbR) through listing additional studies on its platform. Clariness’ global patient portal, ClinLife, has so far randomized more than 75 patients for Klifo Berlin GbR.
Klifo Berlin GbR, a professional research site in the capital of Germany, listed several studies on Clariness’ patient-friendly study platform, ClinLife, in March 2021. Since then, more than 75 patients have been enrolled and randomized thanks to Clariness’ innovative digital engagement campaigns and online screening capabilities.
“Clariness has supported us in patient recruitment in nine studies across six different indications, accelerating recruitment, and increasing screening and randomization numbers” said Isabelle Schenkenberger, Principal Investigator at Klifo Berlin GbR. “Referrals have been constant and consistent, so we’re excited to see the results of continuing patient recruitment through the ClinLife Registry.”
Moritz Kloss, VP of ClinLife Registry, commented, “Our digital targeting and multichannel outreach has extended Klifo Berlin GbR’s patient reach, and driven a significant amount of referrals and randomizations. We’re proud to be continuing our support of Klifo Berlin GbR’s patient recruitment across asthma, COPD, cholesterol/dyslipidemia, and irritable bowel syndrome (IBD), to name a few.”
Clariness’ ClinLife platform is already available in more than 50 countries and 35 different languages, performing recruitment by study and indication to accelerate traditional recruitment timelines. Healthy volunteers and patients who are either suffering from a currently untreatable condition, or dissatisfied with current treatments, can learn more about available studies and enroll in a patient-centric, user-friendly platform.
Clariness offers pharmaceutical companies, contract research organizations (CROs) and study centers worldwide high-quality services for the entire clinical trial lifecycle, including study feasibility, patient recruitment and patient retention.
Its mission is to improve patients’ lives by accelerating the development of medical treatments and therapies. With more than 17 years of experience, Clariness is the leading expert in global patient recruitment. Clariness has a market-leading patient portal, ClinLife®, which is active in more than 50 countries, available in more than 35 languages and covers more than 80 indications. Each year, 15 million people worldwide visit ClinLife.
For more information of Clariness, visit www.clariness.com.
ClinLife® is a patient-friendly digital platform that allows users to search for clinical trials that match their health conditions, educate themselves and apply through digital screeners. Various sponsors, sites, CROs and digital health apps list single studies or entire portfolios of clinical trials on the
ClinLife platform. For more visit www.clinlife.de, or www.clinlife.com.
About Klinische Forschung Berlin
Klinische Forschung Berlin GbR is an owner-managed medical study center that has been treating patients and healthy volunteers in clinical drug studies since 1997.
Further information is available at www.klinische-forschung-berlin.de.